Former Citi CEO Sandy Weill launches new cancer research hub focused on immunotherapy

Core Insights - Former Citigroup CEO Sandy Weill announced a $50 million donation to establish the Weill Cancer Hub East, focusing on cancer treatment through research on nutrition and metabolism [1][2] - The partnership includes four leading research institutions: Princeton University, The Rockefeller University, Weill Cornell Medicine, and the Ludwig Institute for Cancer Research, aiming to enhance immunotherapy strategies [1][2] - The hub will investigate the influence of nutrition and gut microbes on immunotherapy and other cancer treatments, including the effects of GLP-1 agonists [3] Research Focus - The Weill Cancer Hub East will explore how to increase the effectiveness of immunotherapy across various cancer types and patients, addressing a critical scientific question [5] - The hub's projects will involve "reprogramming" the tumor microenvironment and will include clinical trials to test new approaches [4] Previous Initiatives - The Weill Family Foundation previously established the Weill Neurohub in 2019, which focused on developing treatments for neurological and psychiatric diseases by collaborating with researchers from multiple prestigious institutions [6]